Tibetan girl gets permission for kidney transplantTimes of IndiaCHANDIGARH: Dolma Bhuti, 23, a Tibetan national whose kidney transplant surgery was caught in a legal wrangle because of her refugee status, would finally be able to receive the organ as t…
American Red Cross blood drives scheduled in Muskegon, Newaygo and …Muskegon Chronicle – MLive.comJuly 24, 2012 – 10 a.m. to 3:45 p.m., Muskegon Blood Donation Center, 313 W. Webster, Muskegon. July 25, 2012 – 12:30-6:15 p.m., Fruitport Eagles Club, …
This Week in the Medical JournalsGenomeWebAlso in Lancet Oncology, a second team of MD Anderson researchers collaborated with researchers from New Jersey and Puerto Rico in a trial of rituximab combined with lenalidomide to treat relapsed or refractory…
It's the inspiring story of a New Haven woman who had a double lung transplant, a journey that took her right by death's door.
US FDA approves Novartis drug Afinitor for breast cancerReutersThe drug is the first in a class known as mTOR inhibitors to be approved for post-menopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. The European Medicin…
Finally,Tibetan Dolma Bhutti can have kidney transplantIndian ExpressFinally, there is good news for Tibetan national Dolma Bhutti. After a struggle for several months, her kidney transplant will be conducted. For, PGI and the Himachal Pradesh governme…
FDA approves Afinitor for advanced breast cancerFDA.govThe U.S. Food and Drug Administration today approved Afinitor (everolimus) for use in combination with Aromasin (exemestane) to treat certain postmenopausal women with advanced hormone-receptor pos…
TCTMDFew Hospitals Go the Distance to Reduce Readmissions for Heart Failure, AMI …TCTMDThough most hospital administrators claim their institutions seek to reduce preventable readmissions for patients with heart failure or acute myocardial infarction…
BloombergFDA approves Novartis drug Afinitor for breast cancerReuters IndiaThe drug is the first in a class known as mTOR inhibitors to be approved for post-menopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. Afinitor…
Novartis gains FDA approval for Afinitor® in advanced breast cancer marking a …ITNewsThe approval was based on a randomized, double-blind, placebo-controlled, multi- center trial called BOLERO-2 (Breast cancer trials of OraL EveROlimus-2), which eva…